Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
International Society for Gastrointestinal Hereditary Tumours |
RCV000076421 | SCV000107450 | pathogenic | Lynch syndrome | 2013-09-05 | reviewed by expert panel | research | Coding sequence variation introducing premature termination codon |
Labcorp Genetics |
RCV000687066 | SCV000814617 | pathogenic | Hereditary nonpolyposis colorectal neoplasms | 2023-06-24 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ile735Thrfs*10) in the MSH2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MSH2 are known to be pathogenic (PMID: 15849733, 24362816). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 90919). This premature translational stop signal has been observed in individual(s) with Lynch syndrome (PMID: 8872463). This variant is not present in population databases (gnomAD no frequency). |
Myriad Genetics, |
RCV003452894 | SCV004187925 | pathogenic | Lynch syndrome 1 | 2023-08-08 | criteria provided, single submitter | clinical testing | This variant is considered pathogenic. This variant creates a frameshift predicted to result in premature protein truncation. |